chr10-96223879-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_013314.4(BLNK):​c.472G>T​(p.Ala158Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00514 in 1,613,884 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0049 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 48 hom. )

Consequence

BLNK
NM_013314.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.429

Publications

7 publications found
Variant links:
Genes affected
BLNK (HGNC:14211): (B cell linker) This gene encodes a cytoplasmic linker or adaptor protein that plays a critical role in B cell development. This protein bridges B cell receptor-associated kinase activation with downstream signaling pathways, thereby affecting various biological functions. The phosphorylation of five tyrosine residues is necessary for this protein to nucleate distinct signaling effectors following B cell receptor activation. Mutations in this gene cause hypoglobulinemia and absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency in this protein has also been shown in some cases of pre-B acute lymphoblastic leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012]
BLNK Gene-Disease associations (from GenCC):
  • agammaglobulinemia 4, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • autosomal agammaglobulinemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002996534).
BP6
Variant 10-96223879-C-A is Benign according to our data. Variant chr10-96223879-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 252680.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00494 (752/152244) while in subpopulation AMR AF = 0.00628 (96/15296). AF 95% confidence interval is 0.00526. There are 6 homozygotes in GnomAd4. There are 386 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BLNKNM_013314.4 linkc.472G>T p.Ala158Ser missense_variant Exon 6 of 17 ENST00000224337.10 NP_037446.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BLNKENST00000224337.10 linkc.472G>T p.Ala158Ser missense_variant Exon 6 of 17 1 NM_013314.4 ENSP00000224337.6

Frequencies

GnomAD3 genomes
AF:
0.00494
AC:
752
AN:
152126
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.0242
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.0381
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00829
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.00494
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00605
AC:
1521
AN:
251470
AF XY:
0.00611
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00702
Gnomad ASJ exome
AF:
0.0369
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00702
Gnomad NFE exome
AF:
0.00527
Gnomad OTH exome
AF:
0.00912
GnomAD4 exome
AF:
0.00516
AC:
7540
AN:
1461640
Hom.:
48
Cov.:
32
AF XY:
0.00532
AC XY:
3865
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.00143
AC:
48
AN:
33472
American (AMR)
AF:
0.00771
AC:
345
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0353
AC:
923
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00333
AC:
287
AN:
86238
European-Finnish (FIN)
AF:
0.00535
AC:
286
AN:
53414
Middle Eastern (MID)
AF:
0.0167
AC:
93
AN:
5580
European-Non Finnish (NFE)
AF:
0.00466
AC:
5179
AN:
1112006
Other (OTH)
AF:
0.00628
AC:
379
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
451
903
1354
1806
2257
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00494
AC:
752
AN:
152244
Hom.:
6
Cov.:
32
AF XY:
0.00518
AC XY:
386
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41550
American (AMR)
AF:
0.00628
AC:
96
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0381
AC:
132
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4820
European-Finnish (FIN)
AF:
0.00829
AC:
88
AN:
10610
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.00494
AC:
336
AN:
68012
Other (OTH)
AF:
0.00806
AC:
17
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
39
79
118
158
197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00588
Hom.:
24
Bravo
AF:
0.00526
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00767
AC:
66
ExAC
AF:
0.00548
AC:
665
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00791
EpiControl
AF:
0.00859

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Agammaglobulinemia 4, autosomal recessive Benign:4
Apr 19, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 11, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 13, 2022
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is present in the Genome Aggregation Database (Highest reported MAF: 3.7% [382/10370], including 17 homozygotes; https://gnomad.broadinstitute.org/variant/10-97983635-C-A?dataset=gnomad_r2_1), and in ClinVar, with multiple laboratories classifying it as a benign or likely benign (Variation ID: 252680). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, this variant is not expected to cause disease and is classified as benign.

not provided Benign:3
Mar 17, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BLNK: BP4, BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Sep 24, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 18, 2025
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BLNK-related disorder Benign:1
Aug 29, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.098
DANN
Benign
0.45
DEOGEN2
Benign
0.30
T;.;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0065
N
LIST_S2
Benign
0.53
T;T;T
MetaRNN
Benign
0.0030
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.59
N;N;N
PhyloP100
-0.43
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.71
N;N;N
REVEL
Benign
0.032
Sift
Benign
0.55
T;T;T
Sift4G
Benign
0.56
T;T;T
Vest4
0.028
ClinPred
0.0026
T
GERP RS
-6.9
Varity_R
0.039
gMVP
0.13
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148612299; hg19: chr10-97983635; COSMIC: COSV56412312; API